249 related articles for article (PubMed ID: 8194017)
1. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
2. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
3. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
4. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
7. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
[TBL] [Abstract][Full Text] [Related]
9. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
10. PUVA and skin cancer. A historical cohort study on 492 patients.
Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
[TBL] [Abstract][Full Text] [Related]
11. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
12. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
13. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
Nijsten TE; Stern RS
J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
[TBL] [Abstract][Full Text] [Related]
14. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Stern RS; Bagheri S; Nichols K;
J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
[TBL] [Abstract][Full Text] [Related]
15. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
[TBL] [Abstract][Full Text] [Related]
16. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Stern RS; Lunder EJ
Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
19. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
Henseler T; Christophers E; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
[TBL] [Abstract][Full Text] [Related]
20. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
